ClinicalTrials.gov
ClinicalTrials.gov Menu

Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children (PENTA 13)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01982396
Recruitment Status : Completed
First Posted : November 13, 2013
Last Update Posted : November 13, 2013
Sponsor:
Information provided by (Responsible Party):
PENTA Foundation